88 related articles for article (PubMed ID: 9684704)
1. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach.
Lazcano-Ponce EC; Buiatti E; Nájera-Aguilar P; Alonso-de-Ruiz P; Hernández-Avila M
Cancer Causes Control; 1998 May; 9(3):241-51. PubMed ID: 9684704
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico.
Lazcano-Ponce EC; Moss S; Alonso de Ruíz P; Salmerón Castro J; Hernández Avila M
Arch Med Res; 1999; 30(3):240-50. PubMed ID: 10427875
[TBL] [Abstract][Full Text] [Related]
3. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
4. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
5. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
6. The positive experience of screening quality among users of a cervical cancer detection center.
Lazcano-Ponce EC; Moss S; Cruz-Valdez A; de Ruíz PA; Martínez-León CJ; Casares-Queralt S; Hernández-Avila M
Arch Med Res; 2002; 33(2):186-92. PubMed ID: 11886720
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Validity and Reproducibility of the Pap Smear in Mexico: Necessity of a Paradigm Shift.
Yunes-Díaz E; Ruiz PA; Lazcano-Ponce E
Arch Med Res; 2015 May; 46(4):310-6. PubMed ID: 26054968
[TBL] [Abstract][Full Text] [Related]
8. [Cervical cancer screening: knowledge of Pap smear benefits and utilization in Mexico].
Aguilar-Perez JA; Leyva-López AG; Angulo-Nájera D; Salinas A; Lazcano-Ponce EC
Rev Saude Publica; 2003 Feb; 37(1):100-6. PubMed ID: 12488926
[TBL] [Abstract][Full Text] [Related]
9. Barriers to cervical cancer screening in rural Mexico.
Watkins MM; Gabali C; Winkleby M; Gaona E; Lebaron S
Int J Gynecol Cancer; 2002; 12(5):475-9. PubMed ID: 12366665
[TBL] [Abstract][Full Text] [Related]
10. [The factors that determine participation in cervical cancer screening in the state of Morelos].
Lazcano-Ponce EC; Moss S; Cruz-Valdez A; Alonso de Ruiz P; Casares-Queralt S; Martínez-León CJ; Hernández-Avila M
Salud Publica Mex; 1999; 41(4):278-85. PubMed ID: 10624139
[TBL] [Abstract][Full Text] [Related]
11. Has the use of pap smears reduced the risk of invasive cervical cancer in Guadalajara, Mexico?
Jiménez-P rez M; Thomas DB
Int J Cancer; 1999 Sep; 82(6):804-9. PubMed ID: 10446445
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control study.
Hernández-Avila M; Lazcano-Ponce EC; de Ruíz PA; Romieu I
Int J Epidemiol; 1998 Jun; 27(3):370-6. PubMed ID: 9698122
[TBL] [Abstract][Full Text] [Related]
13. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
15. [Quality and performance of pap smears in the cervical cancer screening program in a city of southern Brazil].
Uchimura NS; Nakano K; Nakano LC; Uchimura TT
Rev Assoc Med Bras (1992); 2009; 55(5):569-74. PubMed ID: 19918658
[TBL] [Abstract][Full Text] [Related]
16. Barriers to early detection of cervical-uterine cancer in Mexico.
Lazcano-Ponce EC; Castro R; Allen B; Nájera P; Alonso de Ruíz PA; Hernández-Avila M
J Womens Health; 1999 Apr; 8(3):399-408. PubMed ID: 10326994
[TBL] [Abstract][Full Text] [Related]
17. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.
Dzuba IG; Díaz EY; Allen B; Leonard YF; Lazcano Ponce EC; Shah KV; Bishai D; Lorincz A; Ferris D; Turnbull B; Hernández Avila M; Salmerón J
J Womens Health Gend Based Med; 2002 Apr; 11(3):265-75. PubMed ID: 11988136
[TBL] [Abstract][Full Text] [Related]
18. Quality control study on negative gynecological cytology in Mexico.
Lazcano-Ponce EC; de Ruiz PA; Lopez-Carrillo L; Vazquez-Manriquez ME; Hernandez-Avila M
Diagn Cytopathol; 1994; 10(1):10-4. PubMed ID: 8005035
[TBL] [Abstract][Full Text] [Related]
19. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
